A patent infringement suit filed by New York University and Centocor, Inc., against Abbott Laboratories remains pending. The suit asserts that adalimumab — a drug Abbott sells under the trademark…
Abbott Laboratories’ patent infringement suit against Centocor Inc. relating to Simponi(R) is pending.
Abbott is seeking to enforce certain patent rights that cover the use of fully human anti-TNF alpha antibodies…
A case is pending against Abbott Laboratories in the Eastern District of Texas, in which New York University (NYU) and Centocor, Inc. assert that Humira(R) infringes a patent co-owned by…